Novartis is working to tackle the problem of counterfeit drugs, which are a threat to patient health.

Low- and middle-income countries will account for some three in four of the world’s cancer deaths within the next decade without better access to care. It’s a gap Amy Israel and her team at Novartis are trying to bridge.

An immunologist shares tips from a team-based environment

With extensive experience in public health management, having worked for the International Red Cross, among others, and as a doctor in emergency situations on the ground in Africa and Asia— Ann Aerts discusses the Novartis Foundation's new leprosy strategy.

Improved versions of our new digital platform for heart failure disease management in China have been developed since April, 2020 rollout.